Clinical Trial Update: Efficacy and Safety of HRS-1780 Tablets and Henagliflozin Proline Tablets in Patients With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of HRS-1780 tablets and Henagliflozin Proline tablets in chronic kidney disease. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• HRS-1780 Tablets
• Henagliflozin Proline Tablets

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED